Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Immunotech Laboratories Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Immunotech Laboratories Inc 주요 수익원은 Toys, Games and Gifts이며, 최신 수익 발표에서 수익은 123,419,000입니다. 지역별로는 Far East이 Immunotech Laboratories Inc의 주요 시장이며, 수익은 58,485,000입니다.
Immunotech Laboratories Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Immunotech Laboratories Inc의 순손실은 $-33입니다.